Calnexin as a dual-role biomarker: antibody-based diagnosis and therapeutic targeting in lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Calnexin as a dual-role biomarker: antibody-based diagnosis and therapeutic targeting in lung cancer

Published:2024-02-15 Issue:3 Volume:57 Page:155-160
ISSN:1976-670X
Container-title:BMB Reports
language:en
Short-container-title:BMB Rep

Author:

Lim Soyeon¹,Ha Youngeun¹,Lee Boram¹,Shin Junho¹,Rhim Taiyoun¹^ORCID

Affiliation:

1. Department of Bioengineering, College of Engineering, Hanyang University, Seoul 04763, Korea

Funder

Ministry of Science and ICT, South Korea

Ministry of Trade, Industry and Energy

Ministry of Health and Welfare

Publisher

Korean Society for Biochemistry and Molecular Biology - BMB Reports

Link

https://pdf.medrang.co.kr/BMB/2024/057/BMB057-03-05.pdf

Reference21 articles.

1. Organization WHO. https://www.who.int/news-room/fact-sheets/detail/lung-cancer

2. Cancer statistics, 2022

3. A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients

4. Current and Emerging Treatment Options for Patients With Relapsed Small-cell Lung Carcinoma: A Systematic Literature Review

5. Untargeted Lipidomics of Non-Small Cell Lung Carcinoma Demonstrates Differentially Abundant Lipid Classes in Cancer vs. Non-Cancer Tissue

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydroartemisinin inhibits ATP6 activity, reduces energy metabolism of hepatocellular carcinoma cells, promotes apoptosis and inhibits metastasis via CANX;Oncology Letters;2024-08-02

2. Exosomal microRNAs in lung cancer: a narrative review;Translational Cancer Research;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3